| Mylan is engaged in the global development, licensing, manufacturing, marketing and distributing generic, branded generic, brand-name and over-the-counter pharmaceutical products for resale by others and active pharmaceutical (API) ingredients through three segments, North America, Europe and Rest of World. Co.'s API business is conducted through its subsidiary, Mylan Laboratories Limited. North America segment comprises operations in the U.S. and Canada. Europe segment encompasses operations across countries, including France, Italy, Germany, the U.K. and Spain. Rest of World segment reflects operations in countries outside of its North America and Europe segments. The Mylan NV YTD return is shown above.
The YTD Return on the Mylan NV YTD return page and across the coverage universe of our site,
is a measure of the total return for a given investment year-to-date for the current calendar year
(up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement
period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely
useful in the context of our country's tax system which taxes gains and income on a calendar year basis.
Thus, researching Year-To-Date Returns is good practice for investors — whether Mylan NV YTD return or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the MYL YTD return calculation (with any dividends reinvested as applicable), and to provide a
coverage universe of many stocks and ETFs to be able to compare YTD returns.